Skip to main content
. 2023 Dec 1;7(12):e0332. doi: 10.1097/HC9.0000000000000332

FIGURE 2.

FIGURE 2

(A) Admissions within 180 days of inclusion in the atorvastatin and placebo groups, (B) Liver-related admissions. Comparison of groups by log-rank tests.